ABSTRACT Addition of 12-tetradecanoylphorbol 13-acetate (TPA) to cultures of intact Swiss mouse 3T3 fibroblasts induced a dose-dependent increase in ornithine decarboxylase (OrnDCase) activity. Over the same concentration range, 10-9 to 10-6 M, TPA induced the release of radioactively labeled fibronectin (FN) from the cells into the culture medium. Retinoic acid, a derivative of vitamin A, inhibited in a dose-dependent manner both the increase in OrnDCase activity and the release of FN induced by TPA. To examine the effects of TPA and retinoic acid in enucleated cells, the cells were treated with 7.5 ,.g of cytochalasin B per ml of medium during centrifugation at 10,000 X g for 35 min at 370C. In a series offive experiments, the treated cells were 94.7 ± 4.8% (± SEM) enucleated as measured by [3H]thymidine incorporation and verified by Giesma staining for nuclei. In the enucleated cells, TPA did not induce increased OrnDCase activity but did induce FN release in a dose-dependent fashion over the same concentration range effective for FN release from intact cells. Moreover, addition of retinoic acid to the enucleated cells inhibited the phorbol ester-induced release of FN in a dose-dependent manner. A series of phorbol ester derivatives showed the same order of activity in causing FN release from the enucleated cells as reported for inducing OrnDcase activity in intact cells or in promoting mouse skin tumors in vivo. Similarly, several retinoids were tested for their ability to inhibit the phorbol ester-induced release of FN from enucleated cells. The efficacy of the retinoids in preventing FN release paralleled their activity in inhibiting phorbol ester-induced OrnDCase activity and skin tumor promotion, as reported in the literature. We conclude that at least one aspect of tumor promotion induced by phorbol esters-the loss of FN-does not require the cell nucleus, and further, that retinoids can inhibit this aspect of tumor promotion without nuclear involvement.
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From the recent work of Liau et al. demonstrating the binding of retinol to chromatin (1) and that of Fuchs and Green on the regulation of specific messenger RNA by retinol (2) , one can safely conclude that in its normal physiological function, vitamin A can exert its action through the nucleus. Conversely, ample evidence supports an action ofretinol and other retinoids on the cell surface membrane, especially by influencing membrane glycoproteins (3, 4) . However, the cell surface action could still be mediated through an influence on protein synthesis via the nucleus. Therefore, we set out to determine whether one ofthe cell surface actions of retinoids could be exerted in cells deprived of their nuclei.
Tumor promoters elicit a range of biochemical responses in cells in culture, many of which mimic the activities of transformed or cancer cells. Among these are: stimulation of deoxyglucose uptake (5) , induction of ornithine decarboxylase (OrnDCase) activity (6, 7), decreased cell-substratum adhesion (8) (9) (10) , anchorage-independent growth (10, 11) , changes in cell surface glycoproteins (10, 12) , and loss ofcell surface fibronectin (FN) (13, 14) . In addition 12-tetradecanoylphorbol 13-acetate (TPA), a potent tumor promoter, can induce morphological changes in enucleated mouse skin fibroblasts (15) .
Retinoids, and particularly retinoic acid (RA), inhibit many of these TPA-induced effects, including OrnDCase induction (16) (17) (18) , decreased cell adhesion, and alteration of cell surface glycoproteins (10) . Addition of RA to transformed cells increases their adhesion to substratum (19) and addition to normal cells increases incorporation of radioactive precursors in a Mr 230,000 glycoprotein (20) . Addition of RA to cultures of chondrocytes causes them to accumulate FN as a major cell surface glycoprotein (21) .
Aware Cell Cultures. Swiss mouse 3T3 cells were grown in DME medium supplemented with 10% calf serum, 100 units of penicillin G and 100 ,g ofstreptomycin per ml. Cells were passaged every 3-4 days and were used before the 10th passage. On the day before cells were to be enucleated, they were harvested with 0.1% trypsin and plated at 6 x 105 cells per 25-cm2 tissue culture flask to give a confluent layer of cells 18 hr later. All cultures were kept in 10% C02/90% air.
Enucleation. Cells were enucleated by the method of Nagle and Blumberg (15) After incubation, the cells-were washed twice with DME medium. In enucleation experiments, the cells were enucleated at this point. Enucleated or intact cells were then incubated with DME medium without serum, with phorbol esters or retinoids (or both). Control cultures received neither phorbol esters nor retinoids. At the end of incubation, media were collected and cells were extracted with 4 (24) .
Immunoprecipitation was performed as follows: triplicate 50-to 300-,ul samples in buffer [50 mM Tris HCI, pH 8.3/50 mM NaCl/0.5% deoxycholic acid/2 mM phenylmethylsulfonyl fluoride (PhMeSO2F) to make 400 p1] were incubated with 10 or 20 .14 ofpurified anti-mouse FN antibody for 1 hr at 37C. Three hundred microliters ofa 10% slurry of IgGSorb or 300 A.l of goat anti-rabbit IgG immunobeads were added and the tube was incubated for another hour at 37C (IgGSorb) or overnight at 40C (immunobeads). The tube was centrifuged in a Beckman Microfuge at 12,000 x g for 4 min. The pellet was washed three or four times and transferred to a scintillation vial, and the radioactivity was counted. Incubation mixtures containing sample, but no antiserum, were precipitated to measure nonspecific precipitation. Preimmune serum was substituted for immune serum as a control and did not precipitate radioactivity different from the nonspecific background, routinely < 10% ofthe added radioactivity. For each sample the nonspecific radioactivity was subtracted from the total precipitated radioactivity to give specifically bound radioactivity. The immunoprecipitates were analyzed by NaDodSO4/polyacrylamide gel electrophoresis. In all cases the radioactivity that was precipitated by the immune serum migrated with authentic mouse FN; preimmune serum precipitates gave no bands. Ten microliters of immune serum is sufficient to precipitate 10 pug of FN in this assay, an amount in excess ofthe FN (15) released by TPA treatment from chicken embryo or human lung fibroblasts (14) .
NaDodSO4/polyacrylamide gel electrophoresis was performed in 0.8-or 1.5-mm slab gels with 5% separating gels and 3% stacking gels with the buffers of Weber and Osborn (25) . The gels were stained for protein with Coomassie blue G or subjected to fluorography after being soaked in EN3HANCE. Crosslinked bovine serum albumin and mouse or human FN were used as molecular weight markers.
RESULTS
OrnDCase Induction and FN Release by TPA in Intact Cells. TPA induced dose-dependent OrnDCase activity between 10-9 and 10-6 M (Fig. 1) Figs. 1 and 2 ) was lower than that of intact CB-treated cells (Fig. 3) . Apparently CB itselfcaused increased basal OrnDCase activity.
Release of FN from Enucleated Cells. Fig. 4 though enucleation itself raises the basal level of FN (15) and in the induction ofskin tumors (26) . Similarly, we examined the efficacy offour phorbol esters in inducing FN release from enucleatedc cells (Fig. 5) (Fig. 6) . The structure-activity relationship for retinoids has been well established in two systems: inhibition of skin tumor promotion by TPA (16) and reversal of keratinization in hamster tracheal organ culture (27) . We compared the biological 10 (14) and chicken embryo fibroblasts (13) , to show that TPA also induces FN loss from mouse skin fibroblasts. Nagle and Blumberg have reported that these same 3T3 cells respond to TPA treatment with increased deoxyglucose uptake and altered morphology and have demonstrated a TPA-induced alteration in morphology in enucleated cells (15) . We have now shown that TPA can induce FN loss in enucleated cells and, further, that addition of RA to TPAtreated cells inhibits FN loss.
It has been reported that CB induces the loss of cell surface FN (28) . In these studies, the cells or media or both were examined immediately after the cells were treated with CB. In our experiments, we examined FN release into cell culture medium 4 hr after the removal of CB. We cannot say that CB does not induce some FN release in the 30-min treatment during enucleation, but we do report that after the subsequent 4 
